These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Clinical and hematological improvement in a patient receiving danazol therapy for myelofibrosis with myeloid metaplasia.
    Author: Chabannon C, Pegourie B, Sotto JJ, Hollard D.
    Journal: Nouv Rev Fr Hematol (1978); 1990; 32(2):165-6. PubMed ID: 2377449.
    Abstract:
    We report the positive effect of danazol on clinical and hematological data in a patient with myelofibrosis and myeloid metaplasia. Severe cytopenia was corrected within 2 months and was maintained for an additional 2-month period. Myeloid metaplasia (lymph nodes and skin lesions) was greatly reduced. The patient experienced no side effects. We propose further trials to confirm the utility of this agent in this disease.
    [Abstract] [Full Text] [Related] [New Search]